Saturday, July 11, 2026
🇺🇸 FDA

Drug profile · INN

endocrine

endocrine is an FDA-listed pharmaceutical active ingredient.

NMPA: clinical trials
Patents linked 14
Pipeline programs 47
News articles 0
Drug details — endocrine
Class
—
Route
—
Patents
14
Programs
47
Data quality
0.70
← All drugs Related patents Pipeline programs Drug news hub Event calendar

Quick answer

endocrine is an FDA-listed pharmaceutical active ingredient.

Key facts

INN endocrine

Approval history

Authority Status Date
NMPA clinical trials —

Pipeline programs

Browse pipeline
  1. 1438-0011 Phase 3 · Boehringer Ingelheim · advanced or metastatic extrapulmonary neuroendocrine carcino
  2. 20240178 Phase 3 · Amgen · Extensive stage small cell lung cancer (ES-SCLC).
  3. BAY 3427080, BAY 3427080 60 mg capsules placebo Phase 3 · Bayer · Vasomotor symptoms caused by adjuvant endocrine therapy in w
  4. CAAA601A62301 Phase 3 · Novartis India · Gastroenteropancreatic neuroendocrine tumor (GEP-NET)
  5. Capecitabine plus temozolamide Phase 3 · Hospital Authority · Neuroendocrine Neoplasia's (NENs)
  6. D9670C00001 Phase 3 · AstraZeneca · HER2-Low, Hormone Receptor Positive Breast Cancer which has
  7. GCO-003 TARLANEC Phase 3 · CERo Therapeutics · Advanced pulmonary or gastroenteropancreatic poorly differen
  8. HS-19-657 Phase 3 · Currus Biologics Pty · gastroenteropancreatic neuroendocrine tumors

Related patents

Browse patents

  1. US 12385013

    Differentiation of pancreatic endocrine cells

    Expires Mon Aug 07 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  2. US 12371665

    Differentiation of pancreatic endocrine cells

    Expires Mon Jul 24 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  3. US 12173324

    Differentiation of pancreatic endocrine cells

    Expires Mon Dec 19 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  4. US 12049645

    Differentiation of pancreatic endocrine cells

    Expires Mon Jul 25 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  5. US 12006516

    Differentiation of pancreatic endocrine cells

    Expires Mon Jun 06 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  6. US 2022072166

    METHOD OF TREATMENT OF NEUROENDOCRINE TUMORS

    Expires Wed Mar 05 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  7. US 10865387

    Methods of obtaining pancreatic endocrine cells

    Expires Mon Dec 10 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  8. US 10646435

    Pasty bio-adhesive sustained release compositions

    Expires Mon May 07 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  9. US 7776593

    Hes6 as a marker of pancreatic endocrine cells

    Expires Mon Aug 12 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  10. US 6620808

    Endocrine modulation with positive modulators of AMPA type glutamate receptors

    Expires Mon Sep 11 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  11. US 6413773

    Phosphatidylinositol 3-kinase inhibitors as stimulators of endocrine differentiation

    Expires Mon Jun 27 2022 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  12. US 6329368

    Endocrine modulation with positive modulators of AMPA type glutamate receptors

    Expires Mon Dec 06 2021 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  13. US 6313098

    Methods of neuroendocrine regulation of affective disorders

    Expires Mon Nov 01 2021 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  14. US 6123918

    Hyperolius argus endocrine screen test

    Expires Mon Sep 21 2020 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

Frequently asked questions

What is endocrine?

endocrine is an FDA-listed pharmaceutical active ingredient.

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.